2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Fluzone®: new trials by email Literature Review of Fluzone® trials Research Report on Fluzone®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032) Fluzone®, FluMist® - Influenza | Phase 4 | Terminated | Stanford University | 3 | 2015-09-01 | 2017-05-10 |
| Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031) Fluzone®, FluMist® - Influenza | Phase 4 | Terminated | Stanford University | 10 | 2014-11-19 | 2017-09-12 |
Influenza, Human (2)
United States (1)
Cornelia Dekker, MD (2) · Mark Davis, PhD (2) · K. Christopher Garcia, PhD (1)
U19AI057229 (2)